USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Over the course of two months and 12 treatments, 32 study participants ages 41 to 78 self-treated with the radio waves. Outcomes were evaluated using a questionnaire. One month after treatment, 28 ...

Researchers in the U.K. found that men prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s disease years later. Alzheimer’s Association Dr. Ozama Ismail weighed in.

Erectile dysfunction isn’t just an issue in the bedroom. It could also be an indication of a man’s risk for heart disease and early death. And this holds true, a new study says, regardless of ...

On its clinic website, the supermarket chain said the self-injectable pens can be used once a week to increase a user’s ...

Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive ...

People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. CNN values your feedback 1.

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

For the new study, researchers analyzed the weight loss of more than 18,000 adults who took Mounjaro or Ozempic between May 2022 and September 2023. millaf – stock.adobe.com ...